Physician profile
Robert D Santrock
NPI 1497731780
$7,318,131.27
in general payments reported to CMS, 2019-2025
15 companies · $1.2M in 2025
The $1.2M reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $371K · 2020: $504K · 2021: $949K · 2022: $1.4M · 2023: $1.6M · 2024: $1.3M · 2025: $1.2M.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $3.2M · Consulting Fee: $799K · Travel and Lodging: $52K · Food and Beverage: $9,593 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11.87.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $3,246,759.04 |
| Consulting Fee | $799,300.00 |
| Travel and Lodging | $52,005.54 |
| Food and Beverage | $9,592.97 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $11.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $7,218,841.48 | 2019-2025 | |
| Exactech, INC. | $55,688.77 | 2019-2022 | |
| Vilex LLC | $40,602.62 | 2021-2022 | |
| Medline Industries Lp | $1,771.03 | 2021-2022 | |
| Stryker Corporation | $570.55 | 2022-2024 | Ortholoc 2 Lapifuse, Inbone, Invision |
| Medshape, INC. | $149.68 | 2024 | Dynanail |
| In2bones USA, LLC | $144.09 | 2021 | |
| Wright Medical Technology, INC. | $117.23 | 2019 | |
| Paragon 28, INC. | $97.89 | 2021 | |
| Restor3d, INC. | $76.05 | 2023 | |
| Boston Scientific Corporation | $26.93 | 2023 | |
| Smith+Nephew, INC. | $17.97 | 2024 | Grafix Pl |
| Curonix LLC | $13.60 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Kerecis Limited | $7.70 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Orthofix Medical, INC. | $5.68 | 2025 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Santrock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.